Patents by Inventor Eric K. Engelhard

Eric K. Engelhard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030232334
    Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially lymphoma carcinomas. In addition, the present invention describes the use of novel compositions for use in screening methods.
    Type: Application
    Filed: February 27, 2002
    Publication date: December 18, 2003
    Inventors: David W. Morris, Eric K. Engelhard
  • Publication number: 20030216558
    Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially lymphoma carcinomas. In addition, the present invention describes the use of novel compositions for use in screening methods.
    Type: Application
    Filed: December 20, 2001
    Publication date: November 20, 2003
    Inventors: David W. Morris, Eric K. Engelhard
  • Publication number: 20030194702
    Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially lymphoma carcinomas. In addition, the present invention describes the use of novel compositions for use in screening methods.
    Type: Application
    Filed: October 23, 2001
    Publication date: October 16, 2003
    Inventors: Eric K. Engelhard, David W. Morris
  • Publication number: 20030165878
    Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast cancers. In addition, the present invention describes the use of novel compositions for use in screening methods. The invention provides methods and compositions associated with altered expression of MCM3AP.
    Type: Application
    Filed: March 20, 2002
    Publication date: September 4, 2003
    Inventors: David W. Morris, Eric K. Engelhard
  • Publication number: 20030099963
    Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast cancers. In addition, the present invention describes the use of novel compositions for use in screening methods. The invention provides compositions and methods associated with altered expression of TBX21 in cancer.
    Type: Application
    Filed: March 20, 2002
    Publication date: May 29, 2003
    Inventors: David W. Morris, Eric K. Engelhard
  • Publication number: 20030087252
    Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast cancers. In addition, the present invention describes the use of novel compositions for use in screening methods.
    Type: Application
    Filed: March 20, 2002
    Publication date: May 8, 2003
    Inventors: David W. Morris, Eric K. Engelhard
  • Publication number: 20030064383
    Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast cancers. In addition, the present invention describes the use of novel compositions for use in screening methods. The invention provides compositions and methods associated with altered expression of PRLR in cancer.
    Type: Application
    Filed: March 20, 2002
    Publication date: April 3, 2003
    Inventors: David W. Morris, Eric K. Engelhard
  • Publication number: 20030022255
    Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast carcinomas. In addition, the present invention describes the use of novel compositions for use in screening methods.
    Type: Application
    Filed: December 22, 2000
    Publication date: January 30, 2003
    Inventors: David W. Morris, Eric K. Engelhard
  • Publication number: 20020182586
    Abstract: The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially lymphoma carcinomas. In addition, the present invention describes the use of novel compositions for use in screening methods.
    Type: Application
    Filed: March 1, 2002
    Publication date: December 5, 2002
    Inventors: David W. Morris, Eric K. Engelhard